Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks.
Dowden
Amy M
AM
Rullo
Ornella J
OJ
Aziz
Najib
N
Fasano
Mary Beth
MB
Chatila
Talal
T
Ballas
Zuhair K
ZK
D000208:Acute Disease; D000628:Aminophylline / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D019559:Capillary Leak Syndrome / Q000188:drug therapy* / Q000276:immunology; D002199:Capillary Permeability / Q000187:drug effects; D002648:Child; D016207:Cytokines / Q000097:blood; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D013726:Terbutaline / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D016207:Cytokines; D007155:Immunologic Factors; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D000628:Aminophylline; D000069285:Infliximab; D013806:Theophylline; D013726:Terbutaline